Cognition Therapeutics has announced positive topline outcomes from the double-masked Phase II MAGNIFY trial of zervimesine ...

Discover Ocugen's Q1 2025 earnings insights, focusing on gene therapy advancements, key clinical trials, and financial updates.

Researchers presented an exploratory analysis comparing OCT biomarkers in a Phase 1b study of ONL1204 in patients with ...

The study aims to identify the optimal dose of BI 1584862 and observe its impact on improving GA patients' eyes.

The Supreme Court summons five social media influencers, including Samay Raina, over allegations of mocking individuals with ...